BB Biotech's total assets for Q4 2024 were CHF2.41B, a decrease of -3.94% from the previous quarter. CH:BION total liabilities were CHF121.11M for the fiscal quarter, a -56.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.